News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
402,367 Results
Type
Article (21137)
Company Profile (139)
Press Release (381091)
Multimedia
Podcasts (85)
Webinars (13)
Section
Business (128509)
Career Advice (1416)
Deals (22399)
Drug Delivery (87)
Drug Development (44205)
Employer Resources (140)
FDA (8545)
Job Trends (9912)
News (209602)
Policy (19098)
Tag
Academia (1032)
Accelerated approval (3)
Adcomms (9)
Allergies (47)
Alliances (33503)
ALS (51)
Alzheimer's disease (647)
Antibody-drug conjugate (ADC) (79)
Approvals (8561)
Artificial intelligence (214)
Autoimmune disease (15)
Automation (12)
Bankruptcy (192)
Best Places to Work (7367)
BIOSECURE Act (18)
Biosimilars (64)
Biotechnology (71)
Bladder cancer (43)
Brain cancer (18)
Breast cancer (125)
Cancer (1107)
Cardiovascular disease (97)
Career advice (1194)
Career pathing (25)
CAR-T (69)
Cell therapy (216)
Cervical cancer (10)
Clinical research (36967)
Collaboration (573)
Compensation (235)
Complete response letters (17)
COVID-19 (1154)
CRISPR (32)
C-suite (209)
Cystic fibrosis (60)
Data (1080)
Decentralized trials (1)
Denatured (39)
Depression (22)
Diabetes (124)
Diagnostics (3162)
Digital health (12)
Diversity (8)
Diversity, equity & inclusion (31)
Drug discovery (86)
Drug pricing (104)
Drug shortages (18)
Duchenne muscular dystrophy (47)
Earnings (44674)
Editorial (37)
Employer branding (17)
Employer resources (117)
Events (59896)
Executive appointments (629)
FDA (9304)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (425)
Gene editing (65)
Generative AI (21)
Gene therapy (178)
GLP-1 (473)
Government (2276)
Grass and pollen (3)
Guidances (115)
Healthcare (8378)
Huntington's disease (9)
IgA nephropathy (16)
Immunology and inflammation (57)
Indications (17)
Infectious disease (1225)
Inflammatory bowel disease (73)
Inflation Reduction Act (11)
Influenza (31)
Intellectual property (66)
Interviews (229)
IPO (8819)
IRA (45)
Job creations (2832)
Job search strategy (1026)
Kidney cancer (8)
Labor market (36)
Layoffs (255)
Leadership (17)
Legal (4512)
Liver cancer (31)
Lung cancer (172)
Lymphoma (81)
Machine learning (8)
Management (44)
Manufacturing (267)
MASH (51)
Medical device (5524)
Medtech (5528)
Mergers & acquisitions (13995)
Metabolic disorders (387)
Multiple sclerosis (34)
NASH (16)
Neurodegenerative disease (47)
Neuropsychiatric disorders (13)
Neuroscience (939)
NextGen: Class of 2025 (3758)
Non-profit (1657)
Now hiring (19)
Obesity (213)
Opinion (218)
Ovarian cancer (45)
Pain (66)
Pancreatic cancer (34)
Parkinson's disease (77)
Partnered (16)
Patents (172)
Patient recruitment (45)
Peanut (15)
People (43734)
Pharmaceutical (67)
Pharmacy benefit managers (21)
Phase I (10060)
Phase II (15863)
Phase III (13711)
Pipeline (812)
Policy (141)
Postmarket research (1557)
Preclinical (4223)
Press Release (59)
Prostate cancer (58)
Psychedelics (14)
Radiopharmaceuticals (172)
Rare diseases (250)
Real estate (4198)
Recruiting (59)
Regulatory (13530)
Reports (34)
Research institute (1127)
Resumes & cover letters (231)
Rett syndrome (2)
RNA editing (3)
RSV (13)
Schizophrenia (49)
Series A (74)
Series B (43)
Service/supplier (5)
Sickle cell disease (38)
Special edition (14)
Spinal muscular atrophy (105)
Sponsored (21)
Startups (2419)
State (2)
Stomach cancer (4)
Supply chain (51)
Tariffs (53)
The Weekly (44)
Vaccines (258)
Venture capitalists (28)
Weight loss (144)
Women's health (27)
Worklife (14)
Date
Today (74)
Last 7 days (568)
Last 30 days (1812)
Last 365 days (18131)
2025 (6834)
2024 (19557)
2023 (22363)
2022 (30713)
2021 (32076)
2020 (30864)
2019 (27754)
2018 (21176)
2017 (20047)
2016 (19142)
2015 (22363)
2014 (17456)
2013 (14964)
2012 (16506)
2011 (17103)
2010 (15055)
Location
Africa (508)
Alabama (22)
Alaska (5)
Arizona (112)
Arkansas (5)
Asia (27806)
Australia (3792)
California (3235)
Canada (1328)
China (345)
Colorado (131)
Connecticut (148)
Delaware (81)
Europe (54577)
Florida (534)
Georgia (86)
Idaho (32)
Illinois (379)
India (18)
Indiana (206)
Iowa (7)
Japan (128)
Kansas (79)
Kentucky (18)
Louisiana (8)
Maine (14)
Maryland (439)
Massachusetts (2458)
Michigan (134)
Minnesota (193)
Mississippi (2)
Missouri (40)
Montana (13)
Nebraska (19)
Nevada (30)
New Hampshire (43)
New Jersey (1139)
New Mexico (13)
New York (999)
North Carolina (645)
North Dakota (7)
Northern California (1400)
Ohio (123)
Oklahoma (10)
Oregon (21)
Pennsylvania (724)
Puerto Rico (8)
Rhode Island (18)
South America (802)
South Carolina (21)
Southern California (1231)
Tennessee (56)
Texas (436)
United States (12785)
Utah (79)
Virginia (112)
Washington D.C. (45)
Washington State (208)
West Virginia (3)
Wisconsin (40)
402,367 Results for "sun pharmaceutical industries".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sun Pharma Completes Taro Merger
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) with its subsidiary.
June 24, 2024
·
1 min read
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
Press Releases
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
April 30, 2025
·
2 min read
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Business
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Terns Pharmaceuticals, Inc. announced the appointment of Melita Sun Jung as chief business officer, effective April 22, 2024.
April 10, 2024
·
5 min read
Press Releases
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
April 24, 2025
·
5 min read
Deals
Taro Announces Merger Agreement with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for US$43.00 per share in cash without interest.
January 17, 2024
·
8 min read
Pharm Country
Sun Pharma’s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions
Sun Pharmaceutical Industries Limited announced results from a Phase 1, multiple ascending-dose study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034 in obese adults.
June 22, 2024
·
6 min read
Pharm Country
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that it has called an extraordinary general meeting of its shareholders (the “Extraordinary General Meeting”), to be held on May 22, 2024, at 10:00 a.m., Israel time.
April 15, 2024
·
7 min read
Sun Pharma Canada Launches (PR)ABSORICA LD (isotretinoin capsules) for Treatment of Severe Acne
Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomb: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma”) today announces that PRABSORICA LD (isotretinoin capsules) is now available in Canada.
December 4, 2023
·
5 min read
1 of 40,237
Next
